MUFG Americas’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-300
Closed -$30K 901
2022
Q3
$30K Sell
300
-200
-40% -$21.2K ﹤0.01% 562
2022
Q2
$51K Buy
+500
New +$54.5K ﹤0.01% 509
2020
Q4
Sell
-19,504
Closed -$2.17M 837
2020
Q3
$2.17M Sell
19,504
-50,732
-72% -$5.69M 0.06% 212
2020
Q2
$7.3M Buy
+70,236
New +$7.52M 0.21% 122

Other funds holding BSX.PRA

MUFG Americas's BSX.PRA Position: Q4 2022 in Review

MUFG Americas sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q4 2022, closing a stake of 300 shares — an estimated $30K sold.

MUFG Americas first reported a position in BSX.PRA in Q2 2020 and held it in 4 quarters. The position peaked at $7.3M in Q2 2020. 57 funds tracked by Wall St. Rank hold BSX.PRA as of Q4 2022.

  • MUFG Americas reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q4 2022 after selling out during the quarter.
  • MUFG Americas sold 300 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q4 2022, an estimated $30K.
  • MUFG Americas first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 4 quarters.
  • MUFG Americas's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $7.3M in Q2 2020.
  • 57 funds tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q4 2022.

Based on MUFG Americas's 13F filing for Q4 2022.